Case 9:15-cr-80049-KAM Document 387-21 Entered on FLSD Docket 06/29/2017 Page 1 of 1

Lucentis Purchases and Medicare Payments
Vendor

Amount Paid to
Vendor

Number of J2778
Procedures Billed
to Medicare

Amount Paid by
Medicare to
Melgen

910

Besse

$1,774,500

5,543

$8,425,252

2009

1425

Besse

$2,778,750

6,404

$9,023,761

2010

1400

Besse and
Genentech

$877,500
$1,817,350

6,236

$9,457,304

2011

2200

Genentech

$4,208,600

7,647

$11,440,828

2012

2450

Genentech

$4,662,350

7,682

$11,683,842

1710

Genentech

$3,254,130

5,062

$6,575,973

$19,373,180

38,579

$56,606,960

YEAR

Number of
Vials Purchased

2008

2013
TOTAL

10,095

TOTAL PROFIT FROM LUCENTIS - $37,233,780